首页 > 最新文献

Annali dell'Istituto superiore di sanita最新文献

英文 中文
Suicidal ideation among Italian medical students: prevalence and associated factors from a multicenter study. 意大利医学生的自杀意念:多中心研究的患病率及相关因素
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4415/ANN_21_04_07
Paolo Leombruni, Giuseppina Lo Moro, Fabrizio Bert, Roberta Siliquini

Objectives: To estimate Suicidal Ideation (SI) prevalence among Italian medical students and explore associated factors.

Methods: Multicentre cross-sectional study (2018). Students were enrolled through convenience sampling (sample size=2513). Questionnaires included socio-demographic items and Beck Depression Inventory-II, which has an item on SI. A multivariable regression was performed (p-value<0.05 significant).

Results: SI prevalence was 13.7%. Among students with and without depression SI prevalence was 36.0% and 4.3%. Being female, being in a relationship, good/excellent family cohesion, perceived good economic status were significantly associated with lower SI. Increasing age, bisexual/asexual orientation, psychiatric family history, negative judgment on medical school choice, competitive/hostile climate and unsatisfying friendships among classmates, being worried about not measuring up to the profession significantly increased SI.

Conclusion: There was a high SI prevalence among Italian medical students, consistently with worldwide data. Demographic, relational, and motivational factors seem to influence SI. Determinants should be further investigated to plan university-level interventions.

目的:估计自杀意念(SI)在意大利医学生中的患病率,并探讨相关因素。方法:多中心横断面研究(2018)。学生采用方便抽样(样本量=2513)。问卷包括社会人口统计项目和贝克抑郁量表- ii,其中有一个关于SI的项目。多变量回归(p值)结果:SI患病率为13.7%。在有和没有抑郁症的学生中,SI患病率分别为36.0%和4.3%。女性身份、恋爱关系、良好/优秀的家庭凝聚力、良好的经济地位与较低的SI显著相关。年龄增长、双性恋/无性取向、精神家族史、对医学院选择的负面判断、竞争/敌对的环境和同学之间不满意的友谊、担心不符合职业标准显著增加了SI。结论:意大利医学生的SI患病率较高,与世界范围内的数据一致。人口统计、关系和动机因素似乎影响科学探究。应进一步调查决定因素,以计划大学层面的干预措施。
{"title":"Suicidal ideation among Italian medical students: prevalence and associated factors from a multicenter study.","authors":"Paolo Leombruni,&nbsp;Giuseppina Lo Moro,&nbsp;Fabrizio Bert,&nbsp;Roberta Siliquini","doi":"10.4415/ANN_21_04_07","DOIUrl":"https://doi.org/10.4415/ANN_21_04_07","url":null,"abstract":"<p><strong>Objectives: </strong>To estimate Suicidal Ideation (SI) prevalence among Italian medical students and explore associated factors.</p><p><strong>Methods: </strong>Multicentre cross-sectional study (2018). Students were enrolled through convenience sampling (sample size=2513). Questionnaires included socio-demographic items and Beck Depression Inventory-II, which has an item on SI. A multivariable regression was performed (p-value<0.05 significant).</p><p><strong>Results: </strong>SI prevalence was 13.7%. Among students with and without depression SI prevalence was 36.0% and 4.3%. Being female, being in a relationship, good/excellent family cohesion, perceived good economic status were significantly associated with lower SI. Increasing age, bisexual/asexual orientation, psychiatric family history, negative judgment on medical school choice, competitive/hostile climate and unsatisfying friendships among classmates, being worried about not measuring up to the profession significantly increased SI.</p><p><strong>Conclusion: </strong>There was a high SI prevalence among Italian medical students, consistently with worldwide data. Demographic, relational, and motivational factors seem to influence SI. Determinants should be further investigated to plan university-level interventions.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39734181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic. 多发性骨髓瘤和急性髓性白血病中可测量的残留疾病,一个不断发展的话题。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4415/ANN_21_04_05
Germana Castelli, Elvira Pelosi, Ugo Testa

Minimal or measurable residual disease (MRD) is a term that refers to the submicroscopic tumor disease persisting after therapy. Sensitive immunophenotypic and molecular techniques are used to detect the small amount of residual tumor cells, conferring a detection capacity clearly more sensitive of common cytomorphologic techniques. MRD evaluation now represents an important tool in the study of solid tumors and of hematological malignancies. Concerning hematological malignancies, MRD evaluation was particularly developed in the study of multiple myeloma and acute myeloid leukemia, representing in these diseases a precious biomarker to quantify response to treatment, to evaluate the chemosensitivity/chemoresistance of the disease and to have a prognostic prediction on disease outcome. The finding that MRD evaluation may have a prognostic value, predicting the risk of relapse, stimulated interest in the introduction of MRD in clinical trials, either as a clinical endpoint or as a tool to guide treatment decisions. However, the clinical use of MRD requires a standardization of the techniques used for its detection, the use of multiple techniques and the development of a consistent accuracy and reproducibility. Finally, prospective clinical trials are required to assess the real clinical benefit potentially deriving from the introduction of MRD evaluation into clinical studies.

微小或可测量的残留疾病(MRD)是指治疗后持续存在的亚显微肿瘤疾病。敏感的免疫表型和分子技术用于检测少量残留的肿瘤细胞,赋予检测能力显然比普通细胞形态学技术更敏感。磁共振成像评估现在是研究实体瘤和血液系统恶性肿瘤的重要工具。在血液系统恶性肿瘤方面,MRD评估在多发性骨髓瘤和急性髓系白血病的研究中得到了特别的发展,在这些疾病中,MRD是量化治疗反应、评估疾病的化疗敏感性/化疗耐药性以及对疾病结果进行预后预测的宝贵生物标志物。MRD评估可能具有预测复发风险的预后价值,这一发现激发了在临床试验中引入MRD的兴趣,无论是作为临床终点还是作为指导治疗决策的工具。然而,MRD的临床应用需要其检测技术的标准化,多种技术的使用以及一致的准确性和可重复性的发展。最后,需要前瞻性临床试验来评估将MRD评估引入临床研究可能带来的真正临床益处。
{"title":"Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic.","authors":"Germana Castelli,&nbsp;Elvira Pelosi,&nbsp;Ugo Testa","doi":"10.4415/ANN_21_04_05","DOIUrl":"https://doi.org/10.4415/ANN_21_04_05","url":null,"abstract":"<p><p>Minimal or measurable residual disease (MRD) is a term that refers to the submicroscopic tumor disease persisting after therapy. Sensitive immunophenotypic and molecular techniques are used to detect the small amount of residual tumor cells, conferring a detection capacity clearly more sensitive of common cytomorphologic techniques. MRD evaluation now represents an important tool in the study of solid tumors and of hematological malignancies. Concerning hematological malignancies, MRD evaluation was particularly developed in the study of multiple myeloma and acute myeloid leukemia, representing in these diseases a precious biomarker to quantify response to treatment, to evaluate the chemosensitivity/chemoresistance of the disease and to have a prognostic prediction on disease outcome. The finding that MRD evaluation may have a prognostic value, predicting the risk of relapse, stimulated interest in the introduction of MRD in clinical trials, either as a clinical endpoint or as a tool to guide treatment decisions. However, the clinical use of MRD requires a standardization of the techniques used for its detection, the use of multiple techniques and the development of a consistent accuracy and reproducibility. Finally, prospective clinical trials are required to assess the real clinical benefit potentially deriving from the introduction of MRD evaluation into clinical studies.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39734177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice. 慢性炎症性疾病生物治疗患者乙肝病毒再激活的临床研究
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_08
Lorenzo Ridola, Angelo Zullo, Bruno Laganà, Roberto Lorenzetti, Alberto Migliore, Roberta Pica, Andrea Picchianti Diamanti, Gianfranco Gigliucci, Palma Scolieri, Vincenzo Bruzzese

Introduction and aim: Biologic treatment - particularly with the anti-TNF molecules - is frequently used in clinical practice to treat the severe form for both chronic rheumatic diseases and inflammatory bowel diseases. The immunosuppression induced by biologic therapies increases the risk of infections, including tuberculosis, as well as hepatitis B virus (HBV) reactivation may occur in inactive carriers or occult HBV infection (OBI) subjects during biologic therapy. This study aimed to update data on HBV prevalence and reactivation in patients receiving biologic therapy for either chronic rheumatic diseases or IBD, and to describe their management in clinical practice.

Materials and methods: This study was performed in 6 Italian centers (3 Rheumatology Units and 3 Gastroenterology Units). Clinical, biochemical and virological data, as well as follow up information, were recorded and analyzed.

Results: 984 patients were considered, including 817 with rheumatic disease and 167 with IBD. A total of 43 showed HBV infection (38 OBI and 5 carriers) accounting for a prevalence of 4%. Among OBI patients, 1 (2.6%) case of HBV reactivation occurred in a male patient with Crohn disease. Among the 5 HBV carriers, two patients (1 with spondyloarthritis and 1 with rheumatoid arthritis) did not received HBV antiviral therapy, and both experienced flare of hepatitis at 47 and 49 months following biologic therapy starting.

Discussion: Data of our study highlight that guidelines on management of HBV patients treated with biologic therapies should be still implemented in clinical practice when considering that, although infrequent, HBV reactivation could be potentially life-threatening.

介绍和目的:生物治疗-特别是抗肿瘤坏死因子分子-在临床实践中经常用于治疗慢性风湿性疾病和炎症性肠病的严重形式。生物治疗引起的免疫抑制增加了感染的风险,包括结核病,以及在生物治疗期间,在无活性携带者或隐匿性HBV感染(OBI)受试者中可能发生乙型肝炎病毒(HBV)再激活。本研究旨在更新慢性风湿病或IBD患者接受生物治疗的HBV患病率和再激活数据,并描述其在临床实践中的管理。材料和方法:本研究在意大利6个中心进行(3个风湿病单位和3个胃肠病学单位)。记录并分析临床、生化、病毒学资料及随访资料。结果:共纳入984例患者,其中817例为风湿病,167例为IBD。共有43例HBV感染(OBI 38例,携带者5例),患病率为4%。在OBI患者中,1例(2.6%)男性克罗恩病患者发生HBV再激活。在5名HBV携带者中,2名患者(1名患有脊椎关节炎和1名患有类风湿关节炎)未接受HBV抗病毒治疗,并且在开始生物治疗后47和49个月均出现肝炎爆发。讨论:我们的研究数据强调,考虑到HBV再激活虽然不常见,但可能危及生命,在临床实践中仍应实施生物疗法治疗HBV患者的管理指南。
{"title":"Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice.","authors":"Lorenzo Ridola,&nbsp;Angelo Zullo,&nbsp;Bruno Laganà,&nbsp;Roberto Lorenzetti,&nbsp;Alberto Migliore,&nbsp;Roberta Pica,&nbsp;Andrea Picchianti Diamanti,&nbsp;Gianfranco Gigliucci,&nbsp;Palma Scolieri,&nbsp;Vincenzo Bruzzese","doi":"10.4415/ANN_21_03_08","DOIUrl":"https://doi.org/10.4415/ANN_21_03_08","url":null,"abstract":"<p><strong>Introduction and aim: </strong>Biologic treatment - particularly with the anti-TNF molecules - is frequently used in clinical practice to treat the severe form for both chronic rheumatic diseases and inflammatory bowel diseases. The immunosuppression induced by biologic therapies increases the risk of infections, including tuberculosis, as well as hepatitis B virus (HBV) reactivation may occur in inactive carriers or occult HBV infection (OBI) subjects during biologic therapy. This study aimed to update data on HBV prevalence and reactivation in patients receiving biologic therapy for either chronic rheumatic diseases or IBD, and to describe their management in clinical practice.</p><p><strong>Materials and methods: </strong>This study was performed in 6 Italian centers (3 Rheumatology Units and 3 Gastroenterology Units). Clinical, biochemical and virological data, as well as follow up information, were recorded and analyzed.</p><p><strong>Results: </strong>984 patients were considered, including 817 with rheumatic disease and 167 with IBD. A total of 43 showed HBV infection (38 OBI and 5 carriers) accounting for a prevalence of 4%. Among OBI patients, 1 (2.6%) case of HBV reactivation occurred in a male patient with Crohn disease. Among the 5 HBV carriers, two patients (1 with spondyloarthritis and 1 with rheumatoid arthritis) did not received HBV antiviral therapy, and both experienced flare of hepatitis at 47 and 49 months following biologic therapy starting.</p><p><strong>Discussion: </strong>Data of our study highlight that guidelines on management of HBV patients treated with biologic therapies should be still implemented in clinical practice when considering that, although infrequent, HBV reactivation could be potentially life-threatening.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Legionella pneumophila and SARS-COV-2 co-infection: the importance of laboratory diagnosis. Letter. 嗜肺军团菌与SARS-COV-2合并感染:实验室诊断的重要性。信。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_01
Maria Cristina Rota, Maria Grazia Caporali, Maria Scaturro, Antonietta Girolamo, Xanthi Andrianou, Maria Luisa Ricci
{"title":"Legionella pneumophila and SARS-COV-2 co-infection: the importance of laboratory diagnosis. Letter.","authors":"Maria Cristina Rota,&nbsp;Maria Grazia Caporali,&nbsp;Maria Scaturro,&nbsp;Antonietta Girolamo,&nbsp;Xanthi Andrianou,&nbsp;Maria Luisa Ricci","doi":"10.4415/ANN_21_03_01","DOIUrl":"https://doi.org/10.4415/ANN_21_03_01","url":null,"abstract":"","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39441625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Dioxins and PCBs contamination in milk and dairy products from Province of Taranto (Puglia Region, Southern Italy): a six years spatio-temporal monitoring study. 塔兰托省(意大利南部普利亚地区)牛奶和乳制品中的二恶英和多氯联苯污染:六年时空监测研究。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_06
Orazio Valerio Giannico, Grazia Rita Fragnelli, Simona Baldacci, Francesco Desiante, Angelo Pellegrino, Fabrizio Cosimo Basile, Ettore Franco, Gianfranco Diletti, Michele Conversano

Introduction: Taranto Province (Puglia Region, Southern Italy) is of particular Public Health relevance due to the presence of industrial sources of dioxins and PCBs. The aim of this study was to analyze the spatio-temporal distribution of these pollutants in milk and cheese produced from 2013 to 2018.

Materials and methods: Raw milk and dairy products were sampled in the farms located within 20 km from the industrial area.

Results: 1005 milk samples were collected. Median (IQR) concentrations were: dioxins 0.21 (0.21) pg WHO-TEQ/g fat; dioxins+DL-PCBs 0.83 (0.71) pg WHO-TEQ/g fat; NDL-PCBs 1.92 (1.56) ng/g fat. Overall, only 6 (0.6%) samples were found to be non-compliant for at least one pollutants group. Temporal analysis showed a decreasing trend in dioxins and PCBs concentrations over the observed years and higher values in the first trimester. Spatial analysis showed higher levels of PCBs in areas closest to the industrial pole. 70 dairy products samples were collected. Median pollutants concentrations were far below the EU limits and no exceedances were observed.

Conclusions: The extremely low number of exceedances appeared as an encouraging result and supported the validity of the Public Health measures adopted by the Department of Prevention of Taranto.

导言:塔兰托省(意大利南部普利亚地区)由于存在二恶英和多氯联苯的工业来源,具有特别的公共卫生相关性。本研究的目的是分析2013年至2018年牛奶和奶酪中这些污染物的时空分布。材料和方法:在距工业区20公里范围内的农场取样原料奶和乳制品。结果:共采集牛奶样品1005份。中位(IQR)浓度为:二恶英0.21 (0.21)pg WHO-TEQ/g脂肪;二恶英+ dl -多氯联苯0.83 (0.71)pg WHO-TEQ/g脂肪;NDL-PCBs 1.92 (1.56) ng/g脂肪。总体而言,只有6个(0.6%)样本被发现至少有一个污染物组不符合要求。时间分析显示,二恶英和多氯联苯浓度在观测年份呈下降趋势,在妊娠早期呈较高水平。空间分析显示,在最靠近工业极点的地区,多氯联苯水平较高。采集了70份乳制品样品。污染物浓度中位数远低于欧盟限值,没有发现超标现象。结论:极低的超标次数是一个令人鼓舞的结果,支持了塔兰托省防治厅采取的公共卫生措施的有效性。
{"title":"Dioxins and PCBs contamination in milk and dairy products from Province of Taranto (Puglia Region, Southern Italy): a six years spatio-temporal monitoring study.","authors":"Orazio Valerio Giannico,&nbsp;Grazia Rita Fragnelli,&nbsp;Simona Baldacci,&nbsp;Francesco Desiante,&nbsp;Angelo Pellegrino,&nbsp;Fabrizio Cosimo Basile,&nbsp;Ettore Franco,&nbsp;Gianfranco Diletti,&nbsp;Michele Conversano","doi":"10.4415/ANN_21_03_06","DOIUrl":"https://doi.org/10.4415/ANN_21_03_06","url":null,"abstract":"<p><strong>Introduction: </strong>Taranto Province (Puglia Region, Southern Italy) is of particular Public Health relevance due to the presence of industrial sources of dioxins and PCBs. The aim of this study was to analyze the spatio-temporal distribution of these pollutants in milk and cheese produced from 2013 to 2018.</p><p><strong>Materials and methods: </strong>Raw milk and dairy products were sampled in the farms located within 20 km from the industrial area.</p><p><strong>Results: </strong>1005 milk samples were collected. Median (IQR) concentrations were: dioxins 0.21 (0.21) pg WHO-TEQ/g fat; dioxins+DL-PCBs 0.83 (0.71) pg WHO-TEQ/g fat; NDL-PCBs 1.92 (1.56) ng/g fat. Overall, only 6 (0.6%) samples were found to be non-compliant for at least one pollutants group. Temporal analysis showed a decreasing trend in dioxins and PCBs concentrations over the observed years and higher values in the first trimester. Spatial analysis showed higher levels of PCBs in areas closest to the industrial pole. 70 dairy products samples were collected. Median pollutants concentrations were far below the EU limits and no exceedances were observed.</p><p><strong>Conclusions: </strong>The extremely low number of exceedances appeared as an encouraging result and supported the validity of the Public Health measures adopted by the Department of Prevention of Taranto.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The evaluation of capacity in dementia: ethical constraints and best practice. A systematic review. 痴呆症能力评估:伦理约束和最佳实践。系统回顾。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_04
Marina Gasparini, Valentina Moro, Stefania Amato, Nicola Vanacore, Giuseppe Gambina

The progressive ageing of a population leads to an increase in the number of people suffering from cognitive deterioration. This requires particular attention in terms of the necessity to assess these people's cognitive functions and their capacity to make decisions. The present systematic review analyses the clinical and ethical aspects of any assessment of capacity, with a specific focus on the capacity of the individual to give informed consent for medical treatment and also with regard to their testamentary capacity. The results indicate that the concepts of capacity, competence and decision-making need to be better clarified, ad-hoc devised tools are required and a multidisciplinary, clinical and legal approach to assessments of capacity needs to be adopted. This is crucial to guarantee that the two ethical principles of capacity assessment are adhered to: respect for an individual's autonomy and the protection of fragile individuals.

人口的逐渐老龄化导致认知能力下降的人数增加。这需要特别注意评估这些人的认知功能和决策能力的必要性。本系统审查分析任何能力评估的临床和伦理方面,特别侧重于个人对医疗给予知情同意的能力以及他们的遗嘱能力。结果表明,需要更好地澄清能力、能力和决策的概念,需要特别设计的工具,需要采用多学科、临床和法律的方法来评估能力。这对于保证能力评估的两项道德原则得到遵守是至关重要的:尊重个人的自主权和保护脆弱的个人。
{"title":"The evaluation of capacity in dementia: ethical constraints and best practice. A systematic review.","authors":"Marina Gasparini,&nbsp;Valentina Moro,&nbsp;Stefania Amato,&nbsp;Nicola Vanacore,&nbsp;Giuseppe Gambina","doi":"10.4415/ANN_21_03_04","DOIUrl":"https://doi.org/10.4415/ANN_21_03_04","url":null,"abstract":"<p><p>The progressive ageing of a population leads to an increase in the number of people suffering from cognitive deterioration. This requires particular attention in terms of the necessity to assess these people's cognitive functions and their capacity to make decisions. The present systematic review analyses the clinical and ethical aspects of any assessment of capacity, with a specific focus on the capacity of the individual to give informed consent for medical treatment and also with regard to their testamentary capacity. The results indicate that the concepts of capacity, competence and decision-making need to be better clarified, ad-hoc devised tools are required and a multidisciplinary, clinical and legal approach to assessments of capacity needs to be adopted. This is crucial to guarantee that the two ethical principles of capacity assessment are adhered to: respect for an individual's autonomy and the protection of fragile individuals.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community waterborne outbreak linked to a firefighting response during the COVID-19 emergency. 与COVID-19紧急情况期间的消防反应有关的社区水传播疫情。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_05
Simona Nascetti, Luca Busani, Franco Bartoli, Riccardo Orioli, Alberta Stenico, Dagmar Regele

Background: On 6 March 2020, a big fire in a village forced the firefighters to draw water simultaneously from many sources, including the Adige river. From 9 March, an increasing number of inhabitants reported gastrointestinal symptoms. We describe the outbreak and the challenges linked to the concurrent COVID-19 spread.

Methods: Residents with enteric symptoms and their relatives were interviewed and samples from some of the patients and public water pipelines were tested for enteric pathogens with microbiological and molecular methods.

Results: By 20 March, 182 people reported symptoms and 131 met the case definition. Norovirus GI/GII and other pathogens were found in human and water samples.

Conclusions: Contamination of the public water network with sewage-contaminated river water through the firefighters pressurized water tank was the suspected source of the outbreak. The investigation was partly hampered due to the SARS-CoV-2 emergency. Control measures included avoiding tap water, alternative water supplies and chlorination of public water.

背景:2020年3月6日,一个村庄发生大火,迫使消防员同时从包括阿迪杰河在内的多个来源取水。从3月9日起,越来越多的居民报告出现胃肠道症状。我们描述了疫情以及与COVID-19同时传播相关的挑战。方法:对有肠道症状的居民及其亲属进行访谈,对部分患者和公共供水管道进行肠道病原菌微生物学和分子检测。结果:截至3月20日,182人报告出现症状,131人符合病例定义。在人类和水样中发现了诺如病毒GI/GII和其他病原体。结论:被污水污染的河水经消防队员加压水箱进入公共水网可能是本次疫情的传染源。由于SARS-CoV-2的紧急情况,调查受到了一定程度的阻碍。控制措施包括避免使用自来水、替代供水和对公共用水进行氯化处理。
{"title":"Community waterborne outbreak linked to a firefighting response during the COVID-19 emergency.","authors":"Simona Nascetti,&nbsp;Luca Busani,&nbsp;Franco Bartoli,&nbsp;Riccardo Orioli,&nbsp;Alberta Stenico,&nbsp;Dagmar Regele","doi":"10.4415/ANN_21_03_05","DOIUrl":"https://doi.org/10.4415/ANN_21_03_05","url":null,"abstract":"<p><strong>Background: </strong>On 6 March 2020, a big fire in a village forced the firefighters to draw water simultaneously from many sources, including the Adige river. From 9 March, an increasing number of inhabitants reported gastrointestinal symptoms. We describe the outbreak and the challenges linked to the concurrent COVID-19 spread.</p><p><strong>Methods: </strong>Residents with enteric symptoms and their relatives were interviewed and samples from some of the patients and public water pipelines were tested for enteric pathogens with microbiological and molecular methods.</p><p><strong>Results: </strong>By 20 March, 182 people reported symptoms and 131 met the case definition. Norovirus GI/GII and other pathogens were found in human and water samples.</p><p><strong>Conclusions: </strong>Contamination of the public water network with sewage-contaminated river water through the firefighters pressurized water tank was the suspected source of the outbreak. The investigation was partly hampered due to the SARS-CoV-2 emergency. Control measures included avoiding tap water, alternative water supplies and chlorination of public water.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Italian National Faecal Microbiota Transplantation Program: a coordinated effort against Clostridioides difficile infection. 意大利国家粪便微生物群移植计划:一项针对艰难梭菌感染的协调努力。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_07
Maria Chiara de Stefano, Benedetta Mazzanti, Francesca Vespasiano, Giovanni Cammarota, Gianluca Ianiro, Luca Masucci, Maurizio Sanguinetti, Antonio Gasbarrini, Letizia Lombardini, Massimo Cardillo

Clostridioides (previously Clostridium) difficile infection (CDI) is a common cause of antibiotic-associated diarrhea, whose symptoms range from mild diarrhea to life-threatening pseudomembranous colitis. CDI is characterized by significant recurrence rate following initial resolution and recurrent C. difficile infection (rCDI) represents an onerous burden for the healthcare systems. Conventional antibiotic-based approaches are generally used for the treatment of rCDI but the effective therapy remains elusive. Recently, the faecal microbiota transplantation (FMT) has emerged as an alternative therapeutic strategy against rCDI, with high treatment success rate. In 2018, the Italian National FMT Program was launched, with the aim to provide high quality standards in FMT application to adults with rCDI not responding to antibiotic therapy. Here, we sketch out the key characteristics and the progress of the Italian National FMT Program during the COVID-19 pandemic.

艰难梭菌感染(CDI)是抗生素相关性腹泻的常见原因,其症状从轻度腹泻到危及生命的假膜性结肠炎。CDI的特点是在初始解决后复发率显著,复发性艰难梭菌感染(rCDI)对医疗系统来说是一个沉重的负担。传统的以抗生素为基础的方法通常用于治疗rCDI,但有效的治疗方法仍然难以捉摸。近年来,粪便微生物群移植(FMT)已成为一种治疗rCDI的替代策略,治疗成功率高。2018年,意大利启动了国家FMT计划,旨在为抗生素治疗无反应的成年rCDI患者提供FMT应用的高质量标准。在此,我们概述了2019冠状病毒病大流行期间意大利国家FMT规划的主要特点和进展。
{"title":"The Italian National Faecal Microbiota Transplantation Program: a coordinated effort against Clostridioides difficile infection.","authors":"Maria Chiara de Stefano,&nbsp;Benedetta Mazzanti,&nbsp;Francesca Vespasiano,&nbsp;Giovanni Cammarota,&nbsp;Gianluca Ianiro,&nbsp;Luca Masucci,&nbsp;Maurizio Sanguinetti,&nbsp;Antonio Gasbarrini,&nbsp;Letizia Lombardini,&nbsp;Massimo Cardillo","doi":"10.4415/ANN_21_03_07","DOIUrl":"https://doi.org/10.4415/ANN_21_03_07","url":null,"abstract":"<p><p>Clostridioides (previously Clostridium) difficile infection (CDI) is a common cause of antibiotic-associated diarrhea, whose symptoms range from mild diarrhea to life-threatening pseudomembranous colitis. CDI is characterized by significant recurrence rate following initial resolution and recurrent C. difficile infection (rCDI) represents an onerous burden for the healthcare systems. Conventional antibiotic-based approaches are generally used for the treatment of rCDI but the effective therapy remains elusive. Recently, the faecal microbiota transplantation (FMT) has emerged as an alternative therapeutic strategy against rCDI, with high treatment success rate. In 2018, the Italian National FMT Program was launched, with the aim to provide high quality standards in FMT application to adults with rCDI not responding to antibiotic therapy. Here, we sketch out the key characteristics and the progress of the Italian National FMT Program during the COVID-19 pandemic.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Challenges on the achievement of World Health Organization goals for HCV elimination in Italy: need for a Regional programmatic approach on screening and linkage to care. Commentary. 意大利在实现世界卫生组织消除丙型肝炎病毒目标方面面临的挑战:需要在筛查和与护理联系方面采取区域规划办法。评论。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_02
Loreta A Kondili, Alessio Aghemo, Massimo Andreoni

Italy has been one of the countries with the greatest burden of HCV in Western Europe and with the highest number of HCV liver-related deaths. In order to achieve HCV elimination by 2030 Italy, like many other countries, will need to succeed in tackling the undiagnosed individuals with active HCV infection. To this aim beginning in 2021, a nationwide action has been implemented, consisting of the performance of screening tests among key populations and birth cohorts (1969-1989), estimated to have a high prevalence of undiagnosed individuals. The realization of the proactive screening during the first two years will define the tracks for the whole optimized screening strategy, including also the screening of 1948-1968 birth cohorts, reported to be the best cost-effective strategy in achieving the HCV elimination targets by 2030 in Italy. Each Italian region needs to define the present and future steps to reach HCV elimination goal by 2030 guaranteeing the equity of care.

意大利是西欧丙型肝炎病毒负担最重的国家之一,也是丙型肝炎病毒肝脏相关死亡人数最多的国家之一。为了到2030年消除丙型肝炎病毒,意大利和许多其他国家一样,需要成功地解决未确诊的丙型肝炎病毒活动性感染者。为实现这一目标,从2021年开始实施了一项全国性行动,包括在关键人群和出生队列(1969-1989年)中进行筛查测试,据估计,未确诊个体的患病率很高。在头两年实现主动筛查将确定整个优化筛查策略的轨道,包括1948-1968年出生队列的筛查,据报道,这是在意大利实现到2030年消除HCV目标的最具成本效益的策略。意大利每个地区都需要确定目前和未来的步骤,以实现到2030年消除丙型肝炎病毒的目标,保证护理的公平性。
{"title":"Challenges on the achievement of World Health Organization goals for HCV elimination in Italy: need for a Regional programmatic approach on screening and linkage to care. Commentary.","authors":"Loreta A Kondili,&nbsp;Alessio Aghemo,&nbsp;Massimo Andreoni","doi":"10.4415/ANN_21_03_02","DOIUrl":"https://doi.org/10.4415/ANN_21_03_02","url":null,"abstract":"<p><p>Italy has been one of the countries with the greatest burden of HCV in Western Europe and with the highest number of HCV liver-related deaths. In order to achieve HCV elimination by 2030 Italy, like many other countries, will need to succeed in tackling the undiagnosed individuals with active HCV infection. To this aim beginning in 2021, a nationwide action has been implemented, consisting of the performance of screening tests among key populations and birth cohorts (1969-1989), estimated to have a high prevalence of undiagnosed individuals. The realization of the proactive screening during the first two years will define the tracks for the whole optimized screening strategy, including also the screening of 1948-1968 birth cohorts, reported to be the best cost-effective strategy in achieving the HCV elimination targets by 2030 in Italy. Each Italian region needs to define the present and future steps to reach HCV elimination goal by 2030 guaranteeing the equity of care.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Mortality risk in a population of patients treated for gambling disorders: results of a follow-up study. 赌博障碍治疗人群的死亡风险:一项随访研究的结果。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2021-07-01 DOI: 10.4415/ANN_21_03_03
Raimondo Maria Pavarin, Marco Domenicali, Silvia Marani, Elsa Turino, Fabio Caputo

Aims: To examine mortality risk and causes of death in a cohort of a population of patients treated for gambling disorders in northern Italy from 1992 to 2019.

Methods: Cohort study.

Results: Half of the patients were diagnosed with psychiatric disorders, substance use disorder or alcohol dependence. The excess mortality compared to the general population (SMR) was 1.16 (0.85-1.58), more elevated among females aged 40 to 59 and males aged 20 to 29. Females had higher SMRs for all cancers and suicide; males for malignant neoplasm of liver, of lung, of prostate, and of bladder.

Conclusions: Despite patients increasing, subjects who most turn to the services are the most serious ones, in older age, with comorbid mental disorders and with a compromised health status. This is reflected in the high risk of death for all cancers.

目的:研究1992年至2019年意大利北部一组接受赌博障碍治疗的患者的死亡风险和死亡原因。方法:队列研究。结果:半数患者被诊断为精神障碍、物质使用障碍或酒精依赖。与一般人群(SMR)相比,其超额死亡率为1.16(0.85-1.58),其中40 ~ 59岁女性和20 ~ 29岁男性的超额死亡率更高。女性患所有癌症和自杀的smr都更高;男性患肝、肺、前列腺和膀胱恶性肿瘤。结论:尽管患者数量在增加,但大多数求助于服务的对象是最严重的,年龄较大,伴有精神疾病和健康状况受损的患者。这反映在所有癌症的高死亡率上。
{"title":"Mortality risk in a population of patients treated for gambling disorders: results of a follow-up study.","authors":"Raimondo Maria Pavarin,&nbsp;Marco Domenicali,&nbsp;Silvia Marani,&nbsp;Elsa Turino,&nbsp;Fabio Caputo","doi":"10.4415/ANN_21_03_03","DOIUrl":"https://doi.org/10.4415/ANN_21_03_03","url":null,"abstract":"<p><strong>Aims: </strong>To examine mortality risk and causes of death in a cohort of a population of patients treated for gambling disorders in northern Italy from 1992 to 2019.</p><p><strong>Methods: </strong>Cohort study.</p><p><strong>Results: </strong>Half of the patients were diagnosed with psychiatric disorders, substance use disorder or alcohol dependence. The excess mortality compared to the general population (SMR) was 1.16 (0.85-1.58), more elevated among females aged 40 to 59 and males aged 20 to 29. Females had higher SMRs for all cancers and suicide; males for malignant neoplasm of liver, of lung, of prostate, and of bladder.</p><p><strong>Conclusions: </strong>Despite patients increasing, subjects who most turn to the services are the most serious ones, in older age, with comorbid mental disorders and with a compromised health status. This is reflected in the high risk of death for all cancers.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39444110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annali dell'Istituto superiore di sanita
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1